Metraipolis › archive › dc_fae4338df504
The impact of sugammadex versus neostigmine reversal on return to intended oncological therapy-related outcomes after breast cancer surgery: a retrospective… — Europe PMC PMID:40898363
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40898363
- DOI
- 10.1186/s13741-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T04:43:25.039Z
- SHA-256 of the archived text
47fff90c8453d1650895f5fae2d7aa84aecfa94c65938527d695b906ba58ece4- Stable URL of this page
https://metraipolis.com/documento/dc_fae4338df504
How to cite
The impact of sugammadex versus neostigmine reversal on return to intended oncological therapy-related outcomes after breast cancer surgery: a retrospective… — Europe PMC PMID:40898363 — Europe PMC (en), https://europepmc.org/article/MED/40898363 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fae4338df504 (Metraipolis archive dc_fae4338df504, sha256 47fff90c8453d1650895f5fae2d7aa84aecfa94c65938527d695b906ba58ece4)
BibTeX
@misc{dcfae4338df504,
title = {The impact of sugammadex versus neostigmine reversal on return to intended oncological therapy-related outcomes after breast cancer surgery: a retrospective… — Europe PMC PMID:40898363},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40898363},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fae4338df504; sha256 47fff90c8453d1650895f5fae2d7aa84aecfa94c65938527d695b906ba58ece4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40898363. Agents can read the archived copy with the MCP tool read_document.